Sampre Nutritions to Consider Q2 FY27 Financial Results on 6th Nov'26
Sampre Nutritions Ltd 路 Intimation 路 06 Nov 2026, 5:30 am
Sampre Nutritions to Consider Q2 FY27 Financial Results on 6th Nov'26 Sampre Nutritions Limited has informed BSE that a meeting of its Board of Directors is scheduled for 6th Nov'26. The board will, inter alia, consider and approve the unaudited standalone and consolidated financial results of the company for the second quarter ended 30th Sep'26 for FY27.
Original exchange filing (PDF)
More announcements from Sampre Nutritions Ltd
- In compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015, the unaudited standalone and consolidated financial results along with the limited review report, is attached for .... 路 07 Nov 2026
- Allotment of 1770710 fully paid-up equity shares having a face value of INR 5 each at an issue price of INR 42 each, including a premium of INR 37 each, aggregating to INR 7,43,69,820 only .... 路 25 Sept 2026
- Consolidated Voting Results with the Scrutinizers Report for the 35th Annual General Meeting. 路 06 Sept 2026
- Proceedings of the 35th AGM conducted through Video Conferencing ("VC") / Other Audio-Visual Mode ("OAVM") 路 04 Sept 2026
- Receipt of in-principle / prior approval from BSE for issuance and allotment of 1770710 equity shares of INR 5 each at a price not less than INR 42 each to promoter against conversion of .... 路 30 Aug 2026
- The company has dispatched the letter to all the shareholders holding shares of the company in physical form, containing a QR code that provides direct access to the Annual Report available .... 路 14 Aug 2026
- This is a corrigendum to the Notice of the 35th AGM. There was a typographical error in the date of appointment of the scrutinizer. The said error has been rectified. Neither any material .... 路 14 Aug 2026
- Annual report of the company for the financial year 2025-26. The intimation for the annual report and the notice of the 35th AGM together has been intimated on 10 August 2026. 路 11 Aug 2026
